Combining quinupristin/dalfopristin with other agents for resistant infections.
about
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal managementGram-positive resistance: pathogens, implications, and treatment options: insights from the Society of Infectious Diseases Pharmacists.Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.Safety of intravitreal quinupristin/dalfopristin in an animal model.
P2860
Combining quinupristin/dalfopristin with other agents for resistant infections.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Combining quinupristin/dalfopristin with other agents for resistant infections.
@ast
Combining quinupristin/dalfopristin with other agents for resistant infections.
@en
type
label
Combining quinupristin/dalfopristin with other agents for resistant infections.
@ast
Combining quinupristin/dalfopristin with other agents for resistant infections.
@en
prefLabel
Combining quinupristin/dalfopristin with other agents for resistant infections.
@ast
Combining quinupristin/dalfopristin with other agents for resistant infections.
@en
P2860
P356
P1476
Combining quinupristin/dalfopristin with other agents for resistant infections.
@en
P2093
Burgess B Freeman
P2860
P304
P356
10.1345/APH.1D323
P407
P50
P577
2004-02-27T00:00:00Z